Analytical Data
-
Gene name
KCTD9
- Application
-
Alternative Names
KCTD9; BTB/POZ domain-containing protein KCTD9
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q7L273
-
Expression Region
1-389aa
-
AA Sequence
MRRVTLFLNGSPKNGKVVAVYGTLSDLLSVASSKLGIKATSVYNGKGGLIDDIALIRDDDVLFVCEGEPFIDPQTDSKPPEGLLGFHTDWLTLNVGGRYFTTTRSTLVNKEPDSMLAHMFKDKGVWGNKQDHRGAFLIDRSPEYFEPILNYLRHGQLIVNDGINLLGVLEEARFFGIDSLIEHLEVAIKNSQPPEDHSPISRKEFVRFLLATPTKSELRCQGLNFSGADLSRLDLRYINFKMANLSRCNLAHANLCCANLERADLSGSVLDCANLQGVKMLCSNAEGASLKLCNFEDPSGLKANLEGANLKGVDMEGSQMTGINLRVATLKNAKLKNCNLRGATLAGTDLENCDLSGCDLQEANLRGSNVKGAIFEEMLTPLHMSQSVR
-
Molecular Weight
68.53 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
KCTD9 (Potassium Channel Tetramerization Domain Containing 9) is a protein that has garnered interest in the field of molecular biology and medicine due to its potential roles in cellular processes, such as signaling pathways, cell proliferation, and apoptosis. Recent studies have suggested that KCTD9 may be involved in the modulation of ion channels and the regulation of various signaling cascades, which are critical for maintaining cellular homeostasis. Its expression pattern and functional significance in different tissues have prompted researchers to investigate its implications in various diseases, including cancer and neurological disorders. Additionally, the study of KCTD9's structure and interactions with other proteins could provide insights into its mechanistic roles at the molecular level. By producing recombinant KCTD9 proteins, researchers can conduct detailed functional assays and structural analyses, facilitating a better understanding of the protein's biology. The development of KCTD9 recombinant proteins represents a vital step toward elucidating its specificity and function, which can ultimately lead to the identification of novel therapeutic targets. Furthermore, investigating KCTD9's involvement in disease mechanisms could pave the way for innovative treatment strategies, highlighting the importance of KCTD9 research in the broader context of molecular and clinical studies. This growing body of evidence underscores the necessity for continued exploration of KCTD9's biochemical properties and its potential implications in health and disease.











